Furthermore, we found ANRIL expression was correlated with disease stage, the expression of ANRIL was higher in patients with advanced stage or with lymph node metastasis (LNM) compared with patients with stage I-II or without LNM (Figure 1E,F). This evidence concerns the gene CDKN2B-AS1 and metastatic malignant neoplasm in the lymph nodes.